 |
(1OR)-7-amino-12-fluoro-2,10,16-trimethyl-15 oxo-10,15,16,17-tetrahydro-2H-8,4-(metheno)pyrazolo[4,3-h][2,5,11]benzoxadiazacyclotetradecine-3-carbonitrile |
|---|---|
| Trade Name | |
| Orphan Indication | Non-small cell lung cancer |
| USA Market Approval | USA |
| USA Designation Date | 2015-06-23 00:00:00 |
| Sponsor | Pfizer, Inc.;235 East 42nd Street (M/S 219/9/30);New York, New York, 10017 |
Related Access Program